Return to fertility, toxicology, and transgenerational impact of treatment with WIN 18,446, a potential male contraceptive, in mice
Authors:
- 7 October 2023
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 129, 110306
Abstract
No abstract availableKeywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD098039)
- National Institutes of Health
This publication has 11 references indexed in Scilit:
- Global Deletion of ALDH1A1 and ALDH1A2 Genes Does Not Affect Viability but Blocks SpermatogenesisFrontiers in Endocrinology, 2022
- Effects of quantitative trait loci determining testicular weight in DDD/Sgn inbred mice are strongly influenced by circulating testosterone levelsAsian-Australasian Journal of Animal Sciences, 2019
- Retinoic acid signaling pathwaysDevelopment, 2019
- Can inhibition of retinoic acid biosynthesis function as a non-hormonal female contraceptive?Contraception, 2018
- Two functionally redundant sources of retinoic acid secure spermatogonia differentiation in the seminiferous epitheliumDevelopment, 2018
- Inhibition of Retinoic Acid Biosynthesis by the Bisdichloroacetyldiamine WIN 18,446 Markedly Suppresses Spermatogenesis and Alters Retinoid Metabolism in MiceJournal of Biological Chemistry, 2014
- Proliferative and Nonproliferative Lesions of the Rat and Mouse Male Reproductive SystemToxicologic Pathology, 2012
- Suppression of Spermatogenesis by Bisdichloroacetyldiamines Is Mediated by Inhibition of Testicular Retinoic Acid BiosynthesisJournal of Andrology, 2010
- Meiosis initiation in the human ovary requires intrinsic retinoic acid synthesisHuman Reproduction, 2010
- Suppression of spermatogenesis and chronic toxicity in men by a new series of bis(dichloroacetyl) diaminesToxicology and Applied Pharmacology, 1961